Analysis of the human monocyte-derived macrophage transcriptome and response to lipopolysaccharide provides new insights into genetic aetiology of inflammatory bowel disease

dc.contributor.authorBaillie, J. Kenneth
dc.contributor.authorArner, Erik
dc.contributor.authorDaub, Carsten
dc.contributor.authorDe Hoon, Michael
dc.contributor.authorItoh, Masayoshi
dc.contributor.authorKawaji, Hideya
dc.contributor.authorLassmann, Timo
dc.contributor.authorCarninci, Piero
dc.contributor.authorForrest, Alistair R. R.
dc.contributor.authorHayashizaki, Y
dc.contributor.authorPavli, Paul
dc.date.accessioned2024-02-20T01:24:15Z
dc.date.available2024-02-20T01:24:15Z
dc.date.issued2017
dc.date.updated2022-10-09T07:18:49Z
dc.description.abstractThe FANTOM5 consortium utilised cap analysis of gene expression (CAGE) to provide an unprecedented insight into transcriptional regulation in human cells and tissues. In the current study, we have used CAGE-based transcriptional profiling on an extended dense time course of the response of human monocyte-derived macrophages grown in macrophage colony-stimulating factor (CSF1) to bacterial lipopolysaccharide (LPS). We propose that this system provides a model for the differentiation and adaptation of monocytes entering the intestinal lamina propria. The response to LPS is shown to be a cascade of successive waves of transient gene expression extending over at least 48 hours, with hundreds of positive and negative regulatory loops. Promoter analysis using motif activity response analysis (MARA) identified some of the transcription factors likely to be responsible for the temporal profile of transcriptional activation. Each LPS-inducible locus was associated with multiple inducible enhancers, and in each case, transient eRNA transcription at multiple sites detected by CAGE preceded the appearance of promoter-associated transcripts. LPS-inducible long non-coding RNAs were commonly associated with clusters of inducible enhancers. We used these data to re-examine the hundreds of loci associated with susceptibility to inflammatory bowel disease (IBD) in genome-wide association studies. Loci associated with IBD were strongly and specifically (relative to rheumatoid arthritis and unrelated traits) enriched for promoters that were regulated in monocyte differentiation or activation. Amongst previously-identified IBD susceptibility loci, the vast majority contained at least one promoter that was regulated in CSF1-dependent monocyte-macrophage transitions and/or in response to LPS. On this basis, we concluded that IBD loci are strongly-enriched for monocyte-specific genes, and identified at least 134 additional candidate genes associated with IBD susceptibility from reanalysis of published GWA studies. We propose that dysregulation of monocyte adaptation to the environment of the gastrointestinal mucosa is the key process leading to inflammatory bowel disease.en_AU
dc.description.sponsorshipThis study was supported by an Institute Strategic Programme Grants (BB/G004013/1, BB/I025328/1, BBS/E/D/20211550) from the Biotechnology and Biological Sciences Research Council to The Roslin Institute. JKB is funded by a Wellcome-Beit Prize Intermediate Clinical Fellowship (103258/Z/13/Z,A) and the UK Intensive Care Foundation. FANTOM5 was made possible by a Research Grant for RIKEN Omics Science Center from MEXT to YH and a grant of the Innovative Cell Biology by Innovative Technology (Cell Innovation Program) from the MEXT, Japan to YH. It was also supported by Research Grants for RIKEN Preventive Medicine and Diagnosis Innovation Program to YH and RIKEN Centre for Life Science Technologies, Division of Genomic Technologies (from the MEXT, Japan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.This study was supported by an Institute Strategic Programme Grants (BB/G004013/1, BB/I025328/1, BBS/E/D/20211550) from the Biotechnology and Biological Sciences Research Council to The Roslin Institute. JKB is funded by a Wellcome-Beit Prize Intermediate Clinical Fellowship (103258/Z/13/Z,A) and the UK Intensive Care Foundation. FANTOM5 was made possible by a Research Grant for RIKEN Omics Science Center from MEXT to YH and a grant of the Innovative Cell Biology by Innovative Technology (Cell Innovation Program) from the MEXT, Japan to YH. It was also supported by Research Grants for RIKEN Preventive Medicine and Diagnosis Innovation Program to YH and RIKEN Centre for Life Science Technologies, Division of Genomic Technologies (from the MEXT, Japan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.en_AU
dc.format.mimetypeapplication/pdfen_AU
dc.identifier.issn1553-7390en_AU
dc.identifier.urihttp://hdl.handle.net/1885/313765
dc.language.isoen_AUen_AU
dc.provenanceThis is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.en_AU
dc.publisherPublic Library of Scienceen_AU
dc.rights© 2017 The authorsen_AU
dc.rights.licenseCreative Commons Attribution licenceen_AU
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/en_AU
dc.sourcePLoS Geneticsen_AU
dc.titleAnalysis of the human monocyte-derived macrophage transcriptome and response to lipopolysaccharide provides new insights into genetic aetiology of inflammatory bowel diseaseen_AU
dc.typeJournal articleen_AU
dcterms.accessRightsOpen Accessen_AU
local.bibliographicCitation.issue3en_AU
local.bibliographicCitation.lastpage36en_AU
local.bibliographicCitation.startpage1en_AU
local.contributor.affiliationBaillie, J. Kenneth, University of Edinburghen_AU
local.contributor.affiliationArner, Erik, RIKEN Omics Science Centeren_AU
local.contributor.affiliationDaub, Carsten, RIKEN Omics Science Centeren_AU
local.contributor.affiliationDe Hoon, Michael, RIKEN Omics Science Centeren_AU
local.contributor.affiliationItoh, Masayoshi, RIKEN Omics Science Centeren_AU
local.contributor.affiliationKawaji, Hideya, RIKEN Omics Science Centeren_AU
local.contributor.affiliationLassmann, Timo, University of Western Australiaen_AU
local.contributor.affiliationCarninci, Piero, RIKEN Omics Science Centeren_AU
local.contributor.affiliationForrest, Alistair R. R., RIKEN Omics Science Centeren_AU
local.contributor.affiliationHayashizaki, Y, Tsukuba Instituteen_AU
local.contributor.affiliationPavli, Paul, College of Health and Medicine, ANUen_AU
local.contributor.authoruidPavli, Paul, u3683784en_AU
local.description.notesImported from ARIESen_AU
local.identifier.absfor320406 - Immunogenetics (incl. genetic immunology)en_AU
local.identifier.absfor320209 - Gastroenterology and hepatologyen_AU
local.identifier.ariespublicationu5369653xPUB62en_AU
local.identifier.citationvolume13en_AU
local.identifier.doi10.1371/journal.pgen.1006641en_AU
local.identifier.scopusID2-s2.0-85016560823
local.identifier.thomsonIDWOS:000398043000050
local.publisher.urlhttps://journals.plos.org/en_AU
local.type.statusPublished Versionen_AU

Downloads

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Analysis of the human.pdf
Size:
5.83 MB
Format:
Adobe Portable Document Format
Description: